Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECeDe trial of antenatal betamethasone before elective caesarean section in women with diabetes
ACTRN12623000015640Phase 3Recruiting
- Sponsor
- University of Melbourne
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in respiratory distress syndrome (RDS) comparing Betamethasone with Placebo (2 arms). Primary endpoint: Neonatal respiratory distress. Started Mar 2024; status: recruiting.
02
Drugs
betamethasone sodium
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on ACTRN12623000015640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000015640.